Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

A decline in motor skills is a hallmark of Parkinson's disease, regularly taking the form of slowness, rigidity, and tremors.

Why digital measurements startup Koneksa Health thinks it can help pharma measure if their drugs are effective in people with ...

Hello from San Diego, where I always happen to be, but where this weekend I had the delight of hanging out with coworkers ...

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

"The best medication for Parkinson's will come from Israel. It will be a hybrid medication, and the world's best hybrid ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

which could lead to treatments for the cognitive symptoms of Parkinson's disease ... New Drug Targets for Alzheimer's Identified from Cerebrospinal Fluid Nov. 14, 2024 — Researchers have linked ...

The new Ochsner site will contribute to uncovering additional genes as well as examine health disparities and care access for ...

Although there is no cure, there are ways to relieve the tremors, stiffness, depression, anxiety, and memory problems caused ...

People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital twin’ brain, thanks to a £1m funding ...